# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001628280-24-010870
Filing Date
2024-03-13
Accepted
2024-03-13 15:19:12
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-03-13

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | adct2023annualreport_filin.pdf | ARS | 1629361
| Complete submission text file | 0001628280-24-010870.txt |  | 2245198

Mailing Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066
Business Address BIOPOLE ROUTE DE LA CORNICHE 3B EPALINGES V8 1066 41 21 653 02 00
ADC Therapeutics SA (Filer) CIK: 0001771910 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-39071 | Film No.: 24745771
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)